Novartis signs world’s first licensing deal for high-priced cancer drug

Novartis signs world’s first licensing deal for high-priced cancer drug – Novartis AG agreed to allow generic drugmakers in 7 middle-income nations to produce a leukemia treatment as part of a public health initiative, the first time a voluntary license has been granted for a patented cancer drug.

  • The oral drug called nilotinib is used to treat chronic myeloid leukemia.
  • The Medicines Patent Pool aims to boost access to medicine for people.

★★★★  You Can Also Read  ★★★★

Computer Awareness Quiz Questions Set (Banking)
Read Daily Current Affairs Topic Wise
Daily Current Affairs Quiz (Current GK Test)
Static Gk Quiz Questions and Answers

📣 Prepare Exams is now on Facebook, Twitter, Instagram, YouTube Channel, and Google News to get all the latest News first Like, Follow and bookmark our website @ PrepareExams.com.

For all the latest Updates, download PrepareExams App.

Leave a Comment